Bid guide
How to bid on Industry Partnerships for Childhood Cholestatic Liver Disease Research, NIH
What the agency is buying and why it matters
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), is seeking industry partners. They want collaborators to provide novel therapeutic agents, diagnostic markers, biomarkers, or devices. These will be used in NIH-sponsored multi-center clinical trials and related studies focusing on childhood cholestatic liver diseases.
This opportunity is for organizations that can contribute to research on conditions like biliary atresia, Alagille syndrome, and cystic fibrosis liver disease. The goal is to improve understanding, diagnosis, and treatment outcomes for children and young adults with these rare disorders. Potential areas of collaboration include clinical trials for promising therapies, infant screening techniques, noninvasive imaging methods, and research into disease progression and treatment response.
Key dates and what happens at the deadline
This solicitation was published on September 30, 2024. The deadline for submitting your response is May 31, 2029, at 5:00 PM ET. This is a long-term opportunity, indicating an ongoing interest in collaborations over several years.
By the deadline, interested organizations must have submitted a capability statement. This statement should be no more than 10 pages, plus any necessary appendices. The agency will review these submissions to identify potential partners for their research initiatives.
Who this opportunity suits
This opportunity is suitable for firms in the healthcare sector, specifically those involved in pharmaceuticals, medical devices, diagnostics, or biotechnology. The NIDDK is looking for industry collaborators who can provide Phase I-tested therapeutics, diagnostic markers, biomarkers, or devices.
Companies with expertise in rare childhood liver diseases, clinical trial development, medical imaging, or infant screening technologies would be well-suited. The focus is on advancing research and treatment for conditions causing cholestasis in children.
How to respond
To access the full details of this opportunity, you need to click the “View original source” link. If the first click takes you to the portal’s homepage, click the link again to go directly to the bid.
You might need to create a free account on the portal to view all the associated documents. Once you have reviewed the full solicitation, prepare your capability statement according to the specified page limits and content requirements.
Practical tips for preparing a competitive response
When preparing your capability statement, clearly articulate how your proposed therapeutics, diagnostics, biomarkers, or devices align with the NIDDK's research goals for childhood cholestatic liver diseases. Highlight any existing data or Phase I testing results that demonstrate the potential of your offerings.
Emphasize your organization's experience in clinical research, particularly with pediatric populations or rare diseases, if applicable. Detail your capacity to collaborate effectively with a multi-center consortium like the Childhood Liver Disease Research and Education Network (ChiLDReN). Ensure your submission is concise, well-organized, and directly addresses the agency's stated interests and requirements within the 10-page limit.
See the live bid — deadline, agency details, and how to respond
Dates and requirements can change via addenda; always verify on the bid page and at the original source before responding.
View this bid on BiddingSimpleThis guide was prepared by BiddingSimple from the solicitation’s public posting. It is not official guidance from National Institutes of Health; the original posting controls.